Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2026 11:51 ET | Source: Research and Markets

Global Tumor Models Market Set to Soar from $2.37B in 2026 to $3.57B by 2030 - 3D Spheroids and Organ-on-a-Chip Propel Tumor Model Advancements

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Tumor Models Market Report 2026" has been added to ResearchAndMarkets.com's offering. The tumor models market has been experiencing rapid growth,...
April 02, 2026 11:39 ET | Source: Research and Markets

Stomach Cancer Market Insights, Trends and Innovations Worldwide, 2026-2030 & 2035

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Stomach Cancer Market Report 2026" has been added to ResearchAndMarkets.com's offering. This report provides insights into market dynamics, trends,...
April 02, 2026 10:47 ET | Source: Research and Markets

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

Dublin, April 02, 2026 (GLOBE NEWSWIRE) -- The "Metastatic Lung Adenocarcinoma Treatment Market Report 2026" has been added to ResearchAndMarkets.com's offering. The metastatic lung...
March 27, 2026 10:58 ET | Source: Research and Markets

Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised for Very Strong Growth: Expected to Reach $7.98 Billion by 2030

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Pelvic Cancer Induced Hemorrhagic Cystitis Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pelvic cancer induced...
March 18, 2026 17:31 ET | Source: Marker Therapeutics

Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results

Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in...
March 12, 2026 05:13 ET | Source: Research and Markets

B-cell Inhibitors Market for Non-Oncology Diseases, 2026-2035 Industry Trends and Global Forecasts - Growing Prevalence of Autoimmune Disorders and Hematologic Cancers Drives Rapid Advancement

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "B-cell Inhibitors Market for Non-Oncology Diseases: Industry Trends and Global Forecasts, Till 2035 - Distribution by Stage of Development, Indication...
$Refractory Follicular Lymphoma Diagnostics Market$

January 22, 2026 11:13 ET | Source: Research and Markets

Refractory Follicular Lymphoma Diagnostics Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Refractory Follicular Lymphoma Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
January 22, 2026 06:36 ET | Source: Research and Markets

Global Mantle Cell Lymphoma Market Set for Robust 7.91% CAGR Growth Through 2031

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
December 01, 2025 14:00 ET | Source: CURE Media Group

CURE® and Blood Cancer United® to co-host first Blood Cancer Heroes® event

The inaugural Blood Cancer Heroes® event in Orlando, FL, will honor those who have made tremendous contributions to the blood cancer community.
November 27, 2025 10:10 ET | Source: Research and Markets

Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Follicular Lymphoma Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ...